2014
DOI: 10.1155/2014/957013
|View full text |Cite
|
Sign up to set email alerts
|

Structured Self-Rated Response to Iontophoresis with Verapamil and Dexamethasone in Peyronie’s Disease

Abstract: Introduction. New therapies evolve for the treatment of Peyronie's disease (PD) including the application of dexamethasone and verapamil using Electro Motive Drug Administration (EMDA). Patients and Methods. Patients with PD were routinely offered Potaba, Vitamin E, tamoxifen or colchicine for 6 to 18 months and for those with no improvement, 18 applications of dexamethasone and verapamil using EMDA occurred over a 6 week period. All 30 patients receiving EMDA therapy completed a questionnaire before and after… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 32 publications
(38 reference statements)
0
1
0
Order By: Relevance
“…Studies are continuing on the use of Verapamil, which is also used intralesional, as a topical treatment method. There are data in some studies that Verapamil does not reach the tunica albuginea (33), but dexamethasone and Verapamil applied by ionotophoresis have been shown to reduce the curvature, especially in patients with a curvature degree of less than (30,34).…”
Section: Evidencementioning
confidence: 99%
“…Studies are continuing on the use of Verapamil, which is also used intralesional, as a topical treatment method. There are data in some studies that Verapamil does not reach the tunica albuginea (33), but dexamethasone and Verapamil applied by ionotophoresis have been shown to reduce the curvature, especially in patients with a curvature degree of less than (30,34).…”
Section: Evidencementioning
confidence: 99%